GLP-1 FAQ India — 30+ Questions Answered
Comprehensive answers to the most common questions about GLP-1 therapy, semaglutide eligibility, generic brands, side effects, and treatment in India.
What is semaglutide?
Semaglutide is a GLP-1 receptor agonist drug used for Type 2 diabetes and weight management. Originally sold as Ozempic and Wegovy by Novo Nordisk, generic versions are now available in India from over 40 companies since the patent expired in March 2026. It is administered as a once-weekly injection.
What is the cheapest semaglutide brand in India?
Natco Semanat at approximately ₹1,290 per month in multi-dose vial format. The cheapest pen format is Alkem Semasize at around ₹1,800 per month.
Am I eligible for semaglutide in India?
You may be eligible if your BMI is 25 or above (Indian cutoff), or BMI 23 or above with at least one weight-related condition such as Type 2 diabetes, hypertension, PCOS, or fatty liver. South Asian BMI cutoffs are lower than Western standards.
What are the common side effects of semaglutide?
Nausea (44%), diarrhea (30%), constipation (24%), vomiting (24%), and abdominal pain (20%). Most are mild and resolve within 2-4 weeks at each dose level. Slow dose escalation significantly reduces severity.
Do I need a prescription for semaglutide in India?
Yes. Semaglutide is a Schedule H drug in India. It must be prescribed by a licensed doctor. The DCGI has been cracking down on unauthorized sales since March 2026.
How much weight can I lose with semaglutide?
The STEP 1 trial showed an average of 14.9% body weight loss over 68 weeks. For a 90 kg person, that is roughly 13-15 kg. Individual results vary based on diet, exercise, and adherence.
Are generic semaglutide brands as effective as Ozempic?
Yes. All DCGI-approved generics contain the same active molecule. Dr. Reddy's conducted a Phase 3 trial with 312 participants showing their generic Obeda is non-inferior to Ozempic in efficacy.
What BMI do I need for GLP-1 therapy in India?
South Asian cutoffs: BMI 25+ without comorbidities, or BMI 23+ with at least one weight-related condition. Western cutoffs of 30/27 underestimate risk in Indians.
Who should NOT take semaglutide?
People with personal or family history of medullary thyroid cancer (MTC), MEN2 syndrome, pregnancy, Type 1 diabetes, active pancreatitis, or severe gastroparesis.
What blood tests do I need before starting?
HbA1c, fasting lipid panel, liver function test, kidney function test, thyroid profile (TSH, T3, T4), and Vitamin B12. Total cost at Indian labs: ₹1,500-3,000.
Which doctor should I see for semaglutide?
Endocrinologist (best), diabetologist, or obesity medicine specialist. Consultation cost: ₹500-1,500 in most metros. Available at Apollo, Fortis, Max, Manipal hospitals.
How much does semaglutide cost per year in India?
From ₹15,480/year (Natco Semanat vial) to ₹1,30,200/year (Ozempic pen). Most generic pens cost ₹26,000-50,000 per year.
Is GLP1Score free?
Yes. 100% free. No hidden costs, paywalls, or premium tiers. Take the full assessment, get your score, red flags, brand recommendations, and PDF report at no cost.
Does semaglutide reduce heart attack risk?
Yes. The SELECT trial showed semaglutide reduced major cardiovascular events by 20% in overweight/obese adults with established heart disease.
Vial vs pen vs tablet — which format?
Vials are cheapest (₹1,290-2,000/month) but need syringes. Pens are convenient (₹1,800-4,200/month). Oral tablets (Rybelsus, ₹4,500/month) eliminate injections but have lower bioavailability.
Take the Free GLP-1 Eligibility Assessment